Nephros NEPH
NASDAQ NEPH
$3.59 -0.12 (-3.23%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nephros (NEPH) Gains from Sales and Divestitures (2012 - 2018)

Updated

Nephros' Gains from Sales and Divestitures was $5,000 in FY2024.

Analysis

Nephros (NEPH) Gains from Sales and Divestitures (2012 - 2018) Analysis & Trends

From FY2012 onward, Nephros has reported Gains from Sales and Divestitures for 4 years.

  • The FY2024 figure marks the highest annual Gains from Sales and Divestitures since FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Nephros 38.99 Mn 19.70 Mn 4.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 -10,000.00
Sep 30, 2013 1,000.00
Mar 31, 2013 2,000.00
Dec 31, 2012 55,000.00
API Access

Nephros Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NEPH&period=max&api_key=YOUR_API_KEY